Annual report

VALBIOTIS publishes its 2018 annual report and announces its results.

Read the document


VALBIOTIS obtains the European patent for VALEDIA®.

Read the press release


A major scientific innovation for people with prediabetes.


VALBIOTIS publishes the first prediabetes market data.

Read the press release
S c r o l l




4 products in clinical development

Learn more


VALEDIA® – Prediabetes

• Reduction of the risk of type 2 diabetes
• Phase IIa clinical study ongoing

Learn more



Overweight and /or obesity
• Modulation of intestinal microbiota
• Clinical Phase I/II positive

Learn more



Mild to moderate hypercholesterolemia
• Reduction of blood LDL-cholesterol
• Clinical Phase I/II positive

Learn more


VALEDIA® – Non alcoholic fatty liver

Non-alcoholic fatty liver (NAFL)
• Reduction of NAFL, risk factor for NASH
• Clinical Phase I/II positive

Learn more

Key figures

Patent families filed

All exploitation rights obtained


> 35
75% in R&D

Listed on the Stock Exchange

Euronext Growth

Our last posts


Small Cap Event Invest Securities

En savoir plus

MidCap Portzamparc Conference

En savoir plus

Market Solutions Forum

En savoir plus

Biotech Agora

En savoir plus
Voir tous

VALBIOTIS© listed on the Stock Exchange

Follow us!

17.04.2019 - 15:28

Retrouvez l’interview de Sébastien PELTIER par Jean-Yves Mairé sur Pharmaradio :

16.04.2019 - 07:34

Sébastien PELTIER (CEO)and @Jocelyn Pineau (CFO) meet investors at Small Cap Event organized by Invest Securities.

12.04.2019 - 19:24

10.04.2019 - 07:02

Sébastien PELTIER (CEO) and Jocelyn PINEAU (CFO) meet investors at the 6th edition of the MidCap Conference 2019 organized by @Portzamparc Société de Bourse - Groupe BNP Paribas

09.04.2019 - 14:56

VALBIOTIS accueille 4 étudiants en stage de La Rochelle Université et de l'Université de Poitiers. Bienvenue à Edouard HANNON Agathe FANMUY, Oxana Sidorova et Pauline COUTY !

04.04.2019 - 18:37

Very proud of Laurent LEVY and the Nanobiotix team. Hensify®, a first-in-class radioenhancer, is a wonderful and incredible innovation for millions of people around the world.

See more